LATEST NEWS

First Patients Enrolled in ACT Trial

March 10, 2021

First Patients Enrolled in Uromedica’s Adjustable Continence Therapy (ACT®) for Female Stress Urinary Incontinence (SUI) Trial

Image-empty-state.png

New ProACT Surgical Video

January 18, 2021

New surgical video for the ProACT Adjustable Continence Therapy for Men.

Image-empty-state.png

New ProACT Animation

July 7, 2020

New animation on the ProACT Adjustable Continence Therapy for Men procedure.

Image-empty-state.png

ACT Clinical Trial

January 23, 2020

FDA Approval on the Protocol for the Clinical Investigation on the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence

Image-empty-state.png

New ProACT Paper

April 6, 2020

New OUS ProACT Paper: What if artificial urinary sphincter is not possible? Feasibility and effectiveness of ProACT for patients with persistent stress urinary incontinence after radical prostatectomy treated by sling

Image-empty-state.png

New ProACT Paper

August 20, 2019

New USA ProACT Paper: Adjustable continence therapy (ProACT) for the treatment of male stress urinary incontinence: A systematic review and meta-analysis

Image-empty-state.png

New ProACT Paper

September 3, 2018

New USA ProACT Paper: Treatment with an adjustable long-term implant for post-prostatectomy stress incontinence: The ProACT™ pivotal trial.

Image-empty-state.png

First US Commercial Implant of ProACT

November 2, 2017

Uromedica Announces Successful First US Commercial Implant of ProACT™ Adjustable Continence Therapy for Men

Image-empty-state.png

Launch of ProACT and Reimbursement Coding

July 11, 2017

Uromedica Announces Launch of ProACT™ Adjustable Continence Therapy for Men with FDA Approval and Reimbursement Coding

Image-empty-state.png

French Randomized Trial Between ACT and AMS 800 AUS

July 4, 2016

First patients enrolled in French Randomized Trial Between Uromedica’s Adjustable Continence Therapy (ACT) and Boston Scientific’s AMS 800 Artificial Urinary Sphincter (AUS)

Image-empty-state.png

New ProACT Paper

April 26, 2016

New ProACT Paper in Urology: Maximum Urethral Closure Pressure Increases After Successful Adjustable Continence Therapy (ProACT) for Stress Urinary Incontinence After Radical Prostatectomy by Reuvers et al.

Image-empty-state.png

ProACT PMA Approved by USA FDA

November 24, 2015

Uromedica's ProACT Adjustable Continence Therapy for Men receives PMA Approval from the USA Food and Drug Administration (FDA)

Image-empty-state.png